On September 9, 2025, Inspire Veterinary Partners, Inc. amended its Securities Purchase Agreement to include new institutional investors, resulting in the issuance and sale of 1,253 additional shares of Series B Preferred Stock and related Warrants. This transaction, part of a private placement offering, generated gross proceeds of approximately $1.0 million. The initial agreement, dated July 28, 2025, allowed for up to 10,000 shares of Series B Preferred Stock to be issued and sold to institutional investors. The transactions were conducted without registration under the Securities Act, relying on specific exemptions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Veterinary Partners Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-087649), on September 15, 2025, and is solely responsible for the information contained therein.